Select Bibliography

Filter by any of these (after searching):

Gu, Lin

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 27 items

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - Lancet Respir Med - 2018

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0010

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30607 , CALGB-70701

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer; Results from CALGB 159902

Boylan, Alice M. , Wang, Xiaofei F , Ko, Richard , Watson, Patricia M ... - - J Thorac Cardiovasc Surg - 2013

Manuscript - Secondary - Primary - Respiratory - CALGB-159902

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Demmy, Todd L. , Gu, Lin , Burkhalter, Jack E. , Toloza, Eric M. ... - - J Natl Compr Canc Netw - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30102

Randomized Study of Maintenance Pemetrexed versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Duong, Stephanie ... - - Clin Lung Cancer - 2020

Manuscript - Primary - Primary - Respiratory - CALGB-30901

Randomized phase 2 study of maintenance pemetrexed versus observation for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB/Alliance) 30901

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Stinchcombe, Thomas ... - ASCO - J Clin Oncol - 2019

Abstract - Primary - Primary - Respiratory - CALGB-30901

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Graziano, Stephen L. , Gu, Lin , Wang, Xiaofei , Tatum, Arthur H. ... - - J Thorac Oncol - 2010

Manuscript - Secondary - Primary - Respiratory - CALGB-9633

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Jahan, Thierry , Gu, Lin , Kratzke, Robert , Dudek, Arkadiusz ... - - Lung Cancer - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30107

Biopsy first: Lessons learned from CALGB 140503

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Scalzetti, Ernest ... - - J Thorac Cardiovasc Surg - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - Alliance-A081202 , CALGB-140503 , CALGB-580602

Surgeon Error In Predicting Stage I Non-Small Cell Lung Cancer (NSCLC) Is A Major Factor Precluding Randomization In CALGB 140503 (Alliance)

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Veit, Linda J. ... - AATS - - 2016

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402

Lilenbaum, Rogerio , Wang, Xiaofei , Gu, Lin , Kirshner, Jeffrey ... - - J Clin Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-30402

Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.

Liptay, Michael J , D'amico, Thomas A , Nwogu, Chumy , Demmy, Todd L ... - - J Thorac Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-140203

Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance)

Martin, Linda W. , D'Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J Clin Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Respiratory - Alliance-9761

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

Miller, Antonius A , Wang, Xiaofei F , Gu, Lin , Hoffman, Philip ... - - J Thorac Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30303

Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: Results of Cancer and Leukemia Group B (CALGB) 9782

Monk, J.P. , Halabi, S. , Picus, J. , Hussain, A. , Philips, G. ... - - Cancer - 2012

Manuscript - Primary - Primary - GU - CALGB-9782

VATS Lobectomy Has Better Peri-operative Outcomes than open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)

Nwogu, Chukwumere E. , D'Cunha, Jonathan , Pang, Herbert , Gu, Lin ... - - Ann Thorac Surg - 2015

Manuscript - Primary - Primary - Respiratory - CALGB-31001 , CALGB-140202

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

Perry, Michael C , Kohman, Leslie J , Bonner, James A , Gu, Lin ... - - Clin Lung Cancer - 2007

Manuscript - Primary - Primary - Respiratory - Alliance-9734

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

Ready, Neal E. , Pang, Herbert H. , Gu, Lin , Otterson, Gregory A. ... - - J Clin Oncol - 2015

Manuscript - Primary - Primary - Respiratory - CALGB-30504

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia group B (CALGB) 30106, a CALGB-stratified phase II trial.

Ready, Neal , Jänne, Pasi A , Bogart, Jeffrey , Dipetrillo, Thomas ... - - J Thorac Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-30106 , CALGB-150508

Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance)

Salama, Joseph K. , Gu, Lin , Wang, Xiaofei , Pang, Herbert H. ... - - J Thorac Oncol - 2016

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Pulmonary toxicity in stage III non-small cell lung cancer patients treated with high dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105

Salama, Joseph K. , Stinchcombe, Thomas E. , Gu, Lin , Wang, Xiaofei ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary - Primary - Respiratory - CALGB-30105

PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504 (Alliance)

Salama, Josept K. , Gu, Lin , Wang, Xiaofei , Bogart, Jeffrey ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Switch Maintenance with Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-controlled Phase III Trial

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - MSTO - Int J Radiat Oncol Biol Phys - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

Socinski, Mark A , Blackstock, A William , Bogart, Jeffrey A ... - - J Clin Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30105

Validation of Survival Prognostic Models for Non-Small-Cell Lung Cancer in Stage- and Age-specific Groups

Wang, Xiaofei , Gu, Lin , Zhang, Ying , Sargent, Daniel J. ... - - Lung Cancer - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-8834 , CALGB-8836 , CALGB-8931 , CALGB-8932 , CALGB-9132 , CALGB-9532 , CALGB-140202 , CALGB-140203 , CALGB-30203 , CALGB-30303 , CALGB-30402 , CALGB-30406 , CALGB-30506 , CALGB-30704 , CALGB-39802 , CALGB-39809 , CALGB-39904 , CALGB-9238 , CALGB-9335 , CALGB-9633 , CALGB-9730 , CALGB-9731 , CALGB-9761 , Comprehensive